HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Matteo Menotti Selected Research

Matteo Menotti Research Topics

Disease

4Neoplasms (Cancer)
01/2023 - 11/2014
4Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
01/2023 - 11/2014
4Anaplastic Large-Cell Lymphoma (Ki 1 Lymphoma)
01/2022 - 11/2014
3T-Cell Lymphoma (Lymphoma, T Cell)
01/2022 - 03/2016
3Lymphoma (Lymphomas)
01/2019 - 01/2016
1Non-Hodgkin Lymphoma (Lymphosarcoma)
01/2022

Drug/Important Bio-Agent (IBA)

7Anaplastic Lymphoma KinaseIBA
01/2023 - 11/2014
3Proteins (Proteins, Gene)FDA Link
01/2019 - 01/2016
2Tyrosine Kinase InhibitorsIBA
01/2023 - 12/2015
2Pyridinolcarbamate (P23)IBA
01/2022 - 01/2016
1Peptides (Polypeptides)IBA
01/2023
1Immune Checkpoint InhibitorsIBA
01/2023
1Phosphoric Monoester Hydrolases (Phosphatases)IBA
01/2022
1Protein-Tyrosine Kinases (Tyrosine Kinase)IBA
01/2022
1Wiskott-Aldrich Syndrome ProteinIBA
01/2019
1Guanosine Triphosphate (GTP)IBA
01/2019
1T-Cell Antigen Receptors (T-Cell Receptor)IBA
01/2019
1Mitogen-Activated Protein KinasesIBA
01/2019
1Mitogen-Activated Protein Kinase Kinases (MEKs)IBA
01/2019
1Therapeutic UsesIBA
01/2019
1GTP Phosphohydrolases (GTPases)IBA
03/2016
1Phosphotransferases (Kinase)IBA
01/2016
1Cancer VaccinesIBA
12/2015
1VaccinesIBA
12/2015
1SuspensionsIBA
12/2015
1Bevacizumab (Avastin)FDA Link
11/2014